Skip to main content
UK Government Updates Regulatory Affairs NewsletterUK Government Updates Regulatory Affairs Newsletter Archive

DHSC weekly update (WC 06 May)

Please note this is an extract of the original bulletin. Antimicrobial resistance (AMR) Page summary: Information and resources on the UK’s plans to see antimicrobial resistance contained and controlled by 2040. Change made: Added ‘UK 5-year action plan for antimicrobial resistance 2024 to 2029’. New 5-year plan to combat antimicrobial resistance Page summary: The government has announced its new national…
Tehelj
May 14, 2024
UK Government Updates Regulatory Affairs NewsletterUK Government Updates Regulatory Affairs Newsletter Archive

DHSC weekly update (WC 08 Apr)

Please note this is an extract of the original bulletin. Medical technology strategy: one year on Page summary: Achievements made since the launch of the medtech strategy and the next steps to boost the adoption of medical technology in the NHS. Change made: First published. Medical technology innovation classification framework Page summary: Outlines the aim, scope and definitions of the…
Tehelj
April 17, 2024
UK Government Updates Regulatory Affairs NewsletterUK Government Updates Regulatory Affairs Newsletter Archive

DHSC weekly update (WC 01 Apr)

Please note this is an extract of the original bulletin. Government response to the Regulatory Horizons Council report on neurotechnology Page summary: Minister for Science, Research and Innovation and Minister of State for Health and Secondary Care have responded to recommendations made by the Regulatory Horizons Council on the regulation of neurotechnology. Change made: First published.        …
Tehelj
April 10, 2024
UK Government Updates Regulatory Affairs NewsletterUK Government Updates Regulatory Affairs Newsletter Archive

DHSC weekly update (WC 18 Mar)

Please note this is an extract of the original bulletin. Government response to the report of the equity in medical devices: independent review Page summary: Government’s response to the independent review into racial, ethnic and other factors leading to unfair biases in the design and use of medical devices. Change made: First published.        
Tehelj
March 21, 2024
UK Government Updates Regulatory Affairs NewsletterUK Government Updates Regulatory Affairs Newsletter Archive

DHSC weekly update (WC 19 Feb)

Please note this is an extract of the original bulletin. Funding for game-changing tech which could destroy cancers and predict disease Page summary: Millions invested in eight innovative companies behind lifesaving new medical technology which could destroy liver cancer tumours, detect Alzheimer’s and quickly spot those at risk of stroke Change made: Changed to a more appropriate image    …
Tehelj
February 28, 2024
UK Government Updates Regulatory Affairs NewsletterUK Government Updates Regulatory Affairs Newsletter Archive

Eight innovative technologies selected under IDAP pilot phase

MHRA launched Innovative Devices Access Pathway (IDAP) back in September 2023 to help streamline applications for innovative medical technologies. Today, MHRA have announced that eight innovative medical device technologies are selected for the IDAP. The eight selected innovative devices are: Blood test for Alzheimer’s disease: Roche Diagnostics Ltd has developed an Amyloid Plasma Panel which could help clinicians decide if…
Tehelj
February 14, 2024
UK Government Updates Regulatory Affairs NewsletterUK Government Updates Regulatory Affairs Newsletter Archive

DHSC weekly update (WC 15 Jan)

Please note this is an extract of the original bulletin. Code on Genetic Testing and Insurance Page summary: The agreement between the government and the Association of British Insurers (ABI) on the use of genetic test results in underwriting insurance policies. Change made: First published. Code on Genetic Testing and Insurance: annual report 2023 Page summary: Annual report on agreement…
Tehelj
January 24, 2024
Membership NewsMembership News Archive

DHSC: Red Sea Crisis

Since mid-December there has been significant disruption to global container ship traffic travelling through the Red Sea due to Houthi attacks on commercial vessels. The vast majority of major shipping companies are diverting around the Cape of Good Hope. DHSC understands this could add to journey times and increase shipping costs. It is BIVDA’s opinion this evidences the need for…
Ben Kemp
January 24, 2024